Загрузка...
Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
The only causative treatment for IgE-mediated allergies is allergen-specific immunotherapy. However, fewer than 5% of allergy patients receive immunotherapy because of its long duration and risk of allergic side effects. We aimed at enhancing s.c. immunotherapy by direct administration of allergen i...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
National Academy of Sciences
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2582048/ https://ncbi.nlm.nih.gov/pubmed/19001265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0803725105 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|